Home/Filings/4/0001104659-22-027340
4//SEC Filing

Wagner Kristie Ann 4

Accession 0001104659-22-027340

CIK 0001724344other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 4:30 PM ET

Size

4.9 KB

Accession

0001104659-22-027340

Insider Transaction Report

Form 4
Period: 2022-02-24
Wagner Kristie Ann
VP, Principal Fin & Acct Off
Transactions
  • Award

    Common Stock

    2022-02-24+10,00080,500 total
Footnotes (1)
  • [F1]This award vests in equal 1/4 increments over four years on the anniversary of the date of grant, subject to the reporting person's continued employment with the company.

Issuer

Entasis Therapeutics Holdings Inc.

CIK 0001724344

Entity typeother

Related Parties

1
  • filerCIK 0001911915

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:30 PM ET
Size
4.9 KB